Highly Crosslinked Polybenzoxazines from Monobenzoxazines: The Effect of Meta-Substitution in the Phenol Ring

Autor: Rosa María Sebastián, Jordi Marquet, Hannes Schäfer, Marc Soto, Katharina Koschek, Alba Martos

Publikováno v: Polymers, Vol 12, Iss 2, p 254 (2020)
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Polymers
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
Volume 12
Issue 2

It is possible to control the crosslink density of polymers derived from monobenzoxazines by switching the type of substituents in the phenolic ring and their relative position with respect to the phenol group. We prepared several substituted monoben

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4dc6cd8b5b9e6e58588c092bdb3fa83
https://www.mdpi.com/2073-4360/12/2/254

Polar Groups and Arylsulfonamides: A Good Combination with which to Obtain Supramolecular Columnar Liquid Crystals

Autor: José Luis Serrano, Alba Martos, Angela Zennaro, Joaquín Barberá, Teresa Sierra, Rosa María Sebastián, Cesar Augusto Hincapié

Publikováno v: European Journal of Organic Chemistry. 2013:5331-5340

Financial support from the Spanish Ministerio de Ciencia e Innovacion (MICINN), now: Ministerio de Economia y Competitividad (MINECO) (grant numbers CTQ2011-22649, MAT2009-14636-C03-01, CTQ2009-09030, MAT2012-38538-C03-01, CTQ2012- 35692), Consolider

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::56e4a937f3702a243ce4ecba55902d54
https://doi.org/10.1002/ejoc.201300222

PS-099 Pharmaceutical intervention: enoxaparin use recommendations in patients with renal impairment

Autor: MA Castro-Vida, MJ Gimeno-Jorda, JE Martínez-de la Plata, A Fayet-Peret, Alba Martos-Rosa, Olivia Urquízar-Rodríguez, I Estepa-Moreno, J Urda-Romacho, Pedro José Acosta-Robles

Publikováno v: European Journal of Hospital Pharmacy. 21:A183.2-A183

Background Enoxaparin is a low molecular weight heparin used in the treatment and prophylaxis of thromboembolic disease. It is metabolised in the liver and its elimination is mainly renal. Renal impairment results in a decrease in its elimination and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::44d9fedb668c437b78a71d22bcdbfb16
https://doi.org/10.1136/ejhpharm-2013-000436.449